Dosimetrist for Radiotherapy Treatment Planning | Hull University Teaching Hospitals NHS Trust
| Dyddiad hysbysebu: | 04 Mawrth 2026 |
|---|---|
| Cyflog: | Heb ei nodi |
| Gwybodaeth ychwanegol am y cyflog: | £38,682 - £46,580 per annum |
| Oriau: | Llawn Amser |
| Dyddiad cau: | 03 Ebrill 2026 |
| Lleoliad: | Hull, HU16 5JQ |
| Cwmni: | Hull and East Yorkshire Hospitals NHS Trust |
| Math o swydd: | Parhaol |
| Cyfeirnod swydd: | 7846235/356-26-7846235 |
Crynodeb
HULL UNIVERSITY TEACHING HOSPITALS NHS TRUST
QUEENS CENTRE, CASTLE HILL HOSPITAL
RADIOTHERAPY PHYSICS, MEDICAL PHYSICS DEPARTMENT
Band 6 Dosimetrist for Radiotherapy Treatment Planning and Mould Room
We are offering an opportunity for an enthusiastic registered Dosimetrist/Treatment Planning Radiographer to join our Radiotherapy Physics team, at the Cancer Centre in Cottingham, East Yorkshire.
The successful applicant will join the Radiotherapy Treatment Planning team, a section of Radiotherapy Physics that underpins the Radiotherapy service, which is located in an award-winning facility comprising 6 Linacs, 2 CT scanners, Xstrahl SXR, Papillon-50+ SXR, Flexitron HDR and state-of-the-art Varian (Eclipse) treatment planning system.
You will be joining an established team of Healthcare Science professionals, comprising Clinical Scientists and Technologists, and support staff. The team prides itself on high staff retention and has a pragmatic approach to achieving safe and effective service delivery. We are committed to providing a broad scope for the development of all members of staff.
The department was the first Radiotherapy Centre in the North of England to clinically implement the Varian Halcyon linac, to develop and benefit the patient service, and now has 2 of these units. A Varian TrueBeam has recently been installed, to bring the complement to 4. In addition the department has recently installed SGRT across the fleet.
Building effective relationships with the multidisciplinary Radiotherapy department, and supporting the Lead Dosimetrist and wider planning team in the provision of the Radiotherapy Treatment Planning and Mould Room service, will be fundamental to achieving the high standards expected from this role.
The department has long-standing evidence of research and collaboration, developments in equipment and clinical service, and high commitment to quality and governance; these include implementation of a new and novel image guided treatment for the direct irradiation of rectal cancers using electronic brachytherapy, innovative use of VMAT, 4DCT and image guided treatment techniques.
Our commitment to the utilisation of technology includes the advanced use of electronic quality management systems and extensive use of the Varian ARIA system, which have allowed us to implement innovative process management and paperless working. The department was the first Radiotherapy Physics service to gain UKAS accreditation to the emerging BS70000 MPACE quality standard, evidencing that commitment to the delivery of high-quality clinical service is a core value of the team, and we continue to maintain ISO9001 certification for the entire Radiotherapy service.
The Humber Health Partnership is one of the largest acute and community Partnership arrangements in the NHS, seeing well over one million patients every year and managing a budget of over £1.3 billion.
Made up of two Trusts - Northern Lincolnshire and Goole NHS Foundation Trust (NLAG) and Hull University Teaching Hospitals NHS Trust (HUTH) - our Partnership has significant ambitions and is committed to delivering world-class hospital and community services for the 1.65 million people we serve.
Together we employ nearly 20,000 staff. Our five main hospital sites are Diana, Princess of Wales Hospital, Scunthorpe General Hospital and Goole and District Hospital, for NLAG and Hull Royal Infirmary and Castle Hill Hospital for HUTH.
As Teaching Hospitals working with the Hull York Medical School, we both lead and contribute to research in many areas - biomedical research, primary care, palliative medicine, cardiovascular and respiratory medicine, vascular surgery, cancer surgery and oncology.
We believe that by developing a diverse, inclusive, innovative, skilled and caring workforce, we can deliver excellent care to our patients and a great future for our employees, our Partnership and our community.
For further details with regard to this vacancy opportunity, please see the attached Job Description and Person Specification.
We reserve the right to close the advert early in the event of high levels of interest. Therefore early applications are encouraged.
We welcome applications from candidates who require Skilled Worker Visa sponsorship to work in the UK, and these will be considered alongside all other applications in line with our commitment to equality and inclusion.
Applicants can determine their potential eligibility for a Certificate of Sponsorship by reviewing the Skilled Worker Visa criteria set out by UKVI on the gov.uk website.
This advert closes on Wednesday 18 Mar 2026